FCGR2B and serum lipopolysaccharide activity: In this study, roles of the Syk inhibitor in lupus disease activity and toward innate immune cells (macrophages and neutrophils), in full-blown FcγRIIb−/− lupus mice, an active lupus model with leaky gut-induced endotoxemia and glucanemia [10], were explored.